FDA 510(k) clearance · back to tracker

PROSTATE-63 CANCER DIAGNOSTIC TEST

Asymmetrx cleared K050063 on 2005-02-09, decision: substantially equivalent

K-number

K050063

Sponsor

Asymmetrx

Device

PROSTATE-63 CANCER DIAGNOSTIC TEST

Class

Class I

Decision

Substantially Equivalent

Decision date

2005-02-09

Product code

NTR

Advisory committee

Hematology

Medical specialty

Hematology

Regulation number

864.1860

Official FDA record

Open K050063on accessdata.fda.gov →

FDA's authoritative 510(k) summary page. Includes the decision letter, predicate references, and downloadable substantial-equivalence determination.

openFDA JSON

Raw record →

Machine-readable JSON. Useful for cross-referencing classification, product code, and advisory committee fields.

Use this as a predicate

Drop K050063 into Compass and start a substantial-equivalence draft.

Compass pulls the predicate's intended use, technological characteristics, and performance data, maps them against your device, and produces a draft SE table aligned to FDA's 510(k) program guidance.

Try the sandbox

Source

Public 510(k) database, U.S. Food and Drug Administration, accessed via openFDA. Page refreshed weekly.